Grants and Contributions:
Title:
ARP - Feasibility - Development of CRISPR assay & data used for machine learning
Agreement Number:
934801
Agreement Value:
$50,000.00
Agreement Date:
Sep 16, 2019 - Jul 26, 2020
Description:
Development of a standard operating procedure to generate robust CRISPR-Cas assay data. This data will be used to train machine learning algorithms for the detection and prediction of on/off target effects in CRISPR-Cas assays.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Quebec, Quebec, CA G1P 4P5
Reference Number:
172-2019-2020-Q3-934801
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
798786273
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 50,000 dollars.
Amendment Date
Dec 23, 2019
Recipient's Legal Name:
Ai-Genetika Inc.
Federal Riding Name:
Québec
Federal Riding Number:
24059
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: